BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Immunic, Inc. annonce ses résultats financiers du premier trimestre 2024 et des mises à jour sur l'entreprise Stratégie Financière Immunic Inc Rapport Financier Du Premier Trimestre 2024 Essais Sur La Sclérose En Plaques Traitement De La Maladie Coeliaque
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Zomedica to Participate in EF Hutton Annual Global Conference Zomedica Veterinary Health Investor Meetings EF Hutton Conference NYSE American:ZOM
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Zomedica participera à la conférence mondiale annuelle d'EF Hutton Zomedica Santé Vétérinaire Réunions D'investisseurs Conférence EF Hutton NYSE Américain : ZOM
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago NanoViricides Announces Promising Results with NV-387 in Potentially Treating Smallpox and Mpox NanoViricides NV-387 Tecovirimat Smallpox Mpox
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago NanoViricides annonce des résultats prometteurs avec le NV-387 dans le traitement potentiel de la variole et de la Mpox NanoViricides NV-387 Tecovirimat Variole Mvariole
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Résultats Positifs pour l'Essai Phase 3 SOLARIS sur l’Olanzapine Schizophrénie Medincell TEV-‘749 SOLARIS Olanzapine
BRIEF published on 05/08/2024 at 12:35, 1 year 10 months ago Positive Results for the SOLARIS Phase 3 Trial of Olanzapine Schizophrenia Medincell SOLARIS Olanzapine TEV-'749
BRIEF published on 05/08/2024 at 12:20, 1 year 10 months ago Holcim Shareholders Approve Proposals at 2024 AGM Corporate Governance Dividend Increase Board Elections Shareholder Approvals Holcim AGM 2024
BRIEF published on 05/08/2024 at 12:20, 1 year 10 months ago Les actionnaires de Holcim approuvent les propositions lors de l'AGA 2024 Gouvernance D'Entreprise Augmentation Du Dividende Élections Du Conseil D'administration Approbations Des Actionnaires Assemblée Générale Holcim 2024
BRIEF published on 05/08/2024 at 12:05, 1 year 10 months ago Cannovation Clinical Research Partners Launches, Aiming to Revolutionize Cannabinoid-Based Therapeutics Drug Development Biopharmaceutical Innovation Cannovation Clinical Research Cannabinoid-based Therapeutics Commercialization Strategies
Published on 03/10/2026 at 22:15, 19 minutes ago Avino Reports Exceptional 2025 Results and Advances Multi-Asset Growth Strategy; Significant Improvements Across Key Financial Metrics; Treasury Reaches Record Levels
Published on 03/10/2026 at 21:30, 1 hour 4 minutes ago Mako Mining Files Technical Report for Moss Mine Mineral Resource Estimate
Published on 03/10/2026 at 21:01, 1 hour 33 minutes ago Evergold Announces Non-Brokered Private Placement of up to $5,000,000 for Drilling at Golden Lion, Toodoggone Region, Northern BC
Published on 03/10/2026 at 14:00, 8 hours 34 minutes ago Updated Lineup Announced for the iAccess Alpha Virtual Best Ideas Spring Investment Conference March 10-11, 2026
Published on 03/10/2026 at 21:33, 1 hour ago EQS-Adhoc: Gerresheimer AG: Publication of the 2025 annual and consolidated financial statements only after March 31, 2026, exclusion from the SDAX, postponement of the Annual General Meeting
Published on 03/10/2026 at 19:40, 2 hours 53 minutes ago EQS-Adhoc: Deutsche Rohstoff AG: Preliminary figures for 2025: Revenue above forecast, EBITDA at the upper end of guidance range
Published on 03/10/2026 at 18:57, 3 hours 37 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 03/10/2026 at 18:38, 3 hours 55 minutes ago EQS-Adhoc: NAKIKI SE: Request to convene an extraordinary general meeting
Published on 03/10/2026 at 17:45, 4 hours 49 minutes ago Number of outstanding shares and voting rights as of 28 February 2026
Published on 03/10/2026 at 17:45, 4 hours 49 minutes ago Nombre de droits de vote et d'actions composant le capital social au 28 février 2026
Published on 03/10/2026 at 17:45, 4 hours 49 minutes ago OPmobility reshapes its Executive Committee to further adapt to market needs and accelerate the execution of its strategy
